CPT 88358: Morphometric Tumor Analysis for DNA Ploidy
CPT code 88358 identifies a specialized pathology procedure: morphometric analysis of tumors to evaluate DNA ploidy and quantitative cellular features such as size and shape. This test supports diagnostic and prognostic evaluation in oncology by characterizing chromosomal content and morphologic metrics that can inform clinical interpretation. Nationally, the code matters because it represents a distinct, reportable pathology service with implications for laboratory workflow, coding compliance, and payment policy for tumor characterization services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for morphometric tumor analysis, common settings where the service is provided, and typical coding considerations tied to pathology service lines. The publication outlines available benchmarks and payment considerations where provided, describes relevant clinical scenarios for ordering the test, and summarizes policy and billing elements that affect use of 88358 in laboratory and hospital pathology settings.
Data not available in the input for associated taxonomies, specific ICD-10 pairings, and related codes are noted as unavailable.
Customize your policy alerts
Sign up for cpt 88358 policy alerts
Get alerted when payer policies referencing 88358 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 88358 describes a morphometric analysis of a tumor performed by a clinician, typically a pathologist, to evaluate DNA ploidy (chromosome content) of tumor cells and assess cell size, shape, and other morphologic features. This service is a specialized pathology morphology and morphometry analysis used to characterize neoplastic tissue quantitatively.
-
Service type: Specialized pathology morphometric analysis
-
Typical site of service: Hospital pathology laboratory or reference pathology laboratory